Close Menu

    Subscribe to Updates

    Get the latest information from JBUON.

    What's Hot

    Two Cases of Pancreatic Metastases from Renal Cell Carcinoma and Review of the Literature

    April 17, 2025

    Exploration of Matrix Metalloproteinase-9 and Interleukin-8 in Breast Cancer Patients with No Lymph Node Involvement

    March 14, 2025

    Surgical Treatment of Right Atrial Metastasis of the Malignant Melanoma: A Case Report

    March 6, 2025
    Facebook X (Twitter) Instagram
    JBUONJBUON
    • How to Submit
    • Author Guidelines
    Facebook X (Twitter) Instagram
    SUBMIT
    • Home
    • Browse Issues
      • In Press
      • Current Issue
      • Archives
    • About Journal
      • Journal Information
      • Editorial Board
      • Bibliographic Listings
      • Editorial Policy
      • Ethics and Malpractice Statement
    • For Authors
      • How To Submit
      • Submit Article
      • Downloads
    • Contact
    JBUONJBUON
    Home»Issues»Volume 26, Issue 6»MiR-378a-3p represses malignant behaviors in liver hepatocellular carcinoma via targeting SIRT6
    Volume 26, Issue 6

    MiR-378a-3p represses malignant behaviors in liver hepatocellular carcinoma via targeting SIRT6

    December 1, 2021Updated:April 29, 20242 Mins Read
    Share
    Facebook Twitter Email

    Geqiong Xiao1, Hui Liao1, Mengyu Ding1, Qiong Wang1, Wenwen Zhu1, Jian Chang1, Liang Wang2

    1Department of Oncology, Affiliated Hospital of Shaoxing University, Shaoxing, China

    2Department of Radiology, Affiliated Hospital of Shaoxing University, Shaoxing, China

    Summary

    Purpose: Liver hepatocellular carcinoma (LIHC) is characterized by high recurrence and poor prognosis. This study aimed to explore how miR-378a-3p affects the progression of LIHC.

    Methods: The expression of miR-378a-3p in LIHC and normal tissues, as well as in LIHC cell lines HepG2, 97H, SNU423, SNU449, and SMMC-7721, was detected. Then, miR-378a-3p was overexpressed to evaluate its function on LIHC cell proliferation, migration, and invasion. Bioinformatics analysis was used to predict the target of miR-378a-3p. Subsequently, the effects of SIRT6 on LIHC cell proliferation, migration, and invasion, and the interaction between miR-378a-3p and SIRT6 were investigated. Xenograft models were established to conduct the functional experiment in vivo.

    Results: miR-378a-3p was lowly expressed in LIHC. Moreover, miR-378a-3p overexpression could repress LIHC cell proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT), and meanwhile facilitates its apoptosis. Mechanistically, we determined that miR-378a-3p could directly bind to the 3’-UTR of Human sirtuin 6 (SIRT6). Based on rescue experiment, we found that miR-378a-3p overexpression restrained LIHC cells malignant behaviors, including proliferation, invasion, and EMT process, while which could be remedied by SIRT6 overexpression. More importantly, through injecting miR-378a-3p-agomir into nude mice, we noticed that miR-378a-3p overexpression efficiently suppressed the weight and volume of xenograft tumor, and meanwhile prevented the Ki67 expression and EMT process in tumor formed by miR-378a-3p-overexpressed 97H cells.

    Conclusions: miR-378a-3p/SIRT6 axis could serve as a potential candidate for the treatment of LIHC.

    Keywords: liver hepatocellular carcinoma, miR-378a-3p, SIRT6, tumor, apoptosis, migration, invasion, EMT.

    Full Text: PDF

    Original Article
    Previous ArticleLncRNA00978 contributes to cells growth and metastasis in hepatocellular carcinoma via mediating miR-125b-5p/SOX12 pathway
    Next Article The best evidence for the prevention and management of lower extremity deep venous thrombosis after gynecological malignant tumor surgery: A systematic review and network meta-analysis

    Related Articles

    Exploration of Matrix Metalloproteinase-9 and Interleukin-8 in Breast Cancer Patients with No Lymph Node Involvement

    Volume 27, 2024

    Malignant Diseases as a Reason for Interventions by Emergency Medical Teams in Barajevo 2023

    Volume 27, 2024

    MicroRNA signatures landscape in renal cell carcinoma – related epithelial to mesenchymal transition

    Volume 26, Issue 6
    Don't Miss
    Volume 27, 2024

    Two Cases of Pancreatic Metastases from Renal Cell Carcinoma and Review of the Literature

    April 17, 2025

    Dimosthenis Chrysikos1, Spiros Delis2, Charina Triantopoulou2, Evgenia Charitaki2, Nikos Kokoroskos2, Nikolaos Taprantzis1*, Amir Shihada1, Konstantinos…

    Exploration of Matrix Metalloproteinase-9 and Interleukin-8 in Breast Cancer Patients with No Lymph Node Involvement

    March 14, 2025

    Surgical Treatment of Right Atrial Metastasis of the Malignant Melanoma: A Case Report

    March 6, 2025

    Abdominal Aortic Aneurysm and Radiation Therapy

    October 28, 2024
    Our Picks

    MicroRNA signatures landscape in renal cell carcinoma – related epithelial to mesenchymal transition

    December 1, 2021

    Chromosomal instability landscape in uveal melanoma

    December 1, 2021

    Biomarkers and common oral cancers: Clinical trial studies

    December 1, 2021

    Subscribe to Updates

    About Us
    About Us

    Journal of BUON (Print ISSN: 1107-0625, Electronic ISSN: 2241-6293) is an independent Open Access Journal, published by BAKIS Productions LTD, and appears exclusively on the internet. It is covered/indexed in Current Awareness in Biological Sciences (BIO-BASE), EMBASE/Excerpta Medica.
    We're accepting new manuscripts right now.

    Email Us: editorial_office@jbuon.com
    Contact: Available soon

    Editorial Picks

    MicroRNA signatures landscape in renal cell carcinoma – related epithelial to mesenchymal transition

    December 1, 2021

    Chromosomal instability landscape in uveal melanoma

    December 1, 2021

    Biomarkers and common oral cancers: Clinical trial studies

    December 1, 2021
    Get in Touch

    Editor-in-Chief
    Athanasios E. Athanasiou,
    Department of Medical Oncology,
    Metaxa Cancer Hospital, Botassi 51, 18537, Piraeus, Greece
    Editorial Office: editorial_office@jbuon.com

    Publishing support
    EManuscript Technologies
    # 9, First Floor, Vinnse Towers
    Wheeler Road Extension, St. Thomas Town, Bangalore 560 084, INDIA
    E: journals@emanuscript.in 
    W : www.emanuscript.in

     

    • Home
    • Author Guidelines
    • Site Map
    • Contact Us
    © 2025 JBUON Powered by EManuscript.

    Type above and press Enter to search. Press Esc to cancel.